WB (FAQ Protocol), ELISA (FAQ Protocol), IP (FAQ Protocol)
Species reactivity
Reacts with: Human
Specificity
Human Adenosine Deaminase
Immunogen
Recombinant Human Adenosine Deaminase Protein (Catalog#14737-H08B)
Preparation
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Adenosine Deaminase (rh Adenosine Deaminase; Catalog#14737-H08B; P00813; Met1-Leu363). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Source
Monoclonal Mouse IgG1 Clone #04
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
Synonyms: Anti-ADA1 Antibody
Image / Experimental Information
Image 1 Description
ADA was immunoprecipitated using: Lane A:0.5 mg Jurkat Whole Cell Lysate 4 µL anti-ADA mouse monoclonal antibody and 60 μg of Immunomagnetic beads Protein A/G. Primary antibody: Anti-ADA mouse monoclonal antibody,at 1:100 dilution Secondary antibody: Rabbit Anti-Mouse IgG F(ab)2/HRP at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 41 kDa Observed band size :41 kDa
Image 1 Alt Text
Human Adenosine Deaminase Immunoprecipitation(IP) 43955
ADA was immunoprecipitated using: Lane A:0.5 mg Jurkat Whole Cell Lysate 4 µL anti-ADA mouse monoclonal antibody and 60 μg of Immunomagnetic beads Protein A/G. Primary antibody: Anti-ADA mouse monoclonal antibody,at 1:100 dilution Secondary antibody: Rabbit Anti-Mouse IgG F(ab)2/HRP at 1/10000 dilution Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 41 kDa Observed band size :41 kDa
Adenosine Desaminase (ADA) deficiency, is a purine metabolic disorder that cause severe combined immunodeficiency (SCID) due to the accumulation of toxic metabolites that primarily affects development, differentiation and function of T and B lymphocytes. Adenosine deaminase is a polymorphic enzyme that has an important role in immune functions and in the regulation of intracellular and extracellular concentrations of adenosine and adenosine receptor activity. ADA activity might be considered as a useful diagnostic tool among the other markers in these diseases. Genetic variability of ADA activity may have, therefore, an important role in resistance to malaria. Adenosine Deaminase (ADA) deficiency is an autosomal recessive variant of severe combined immunodeficiency (SCID) caused by systemic accumulation of ADA substrates.